BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21576577)

  • 1. Fox-Fordyce disease following axillary laser hair removal.
    Tetzlaff MT; Evans K; DeHoratius DM; Weiss R; Cotsarelis G; Elenitsas R
    Arch Dermatol; 2011 May; 147(5):573-6. PubMed ID: 21576577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary Fox-Fordyce-like disease induced by laser hair removal therapy.
    Yazganoğlu KD; Yazici S; Büyükbabani N; Ozkaya E
    J Am Acad Dermatol; 2012 Oct; 67(4):e139-40. PubMed ID: 22980266
    [No Abstract]   [Full Text] [Related]  

  • 3. Fox Fordyce disease as a secondary effect of laser hair removal.
    Bernad I; Gil P; Lera JM; Giménez de Azcárate A; Irarrazaval I; Idoate MÁ
    J Cosmet Laser Ther; 2014 Jun; 16(3):141-3. PubMed ID: 24131099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fox-Fordyce-like disease following laser hair removal appearing on all treated areas.
    Helou J; Maatouk I; Moutran R; Obeid G
    Lasers Med Sci; 2013 Jul; 28(4):1205-7. PubMed ID: 23318918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fox-Fordyce Disease: An under-diagnosed adverse event of laser hair removal?
    Sammour R; Nasser S; Debahy N; El Habr C
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1578-82. PubMed ID: 27135989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lesions in the axilla after hair removal using intense pulsed light. Fox-Fordyce disease.
    Alés-Fernández M; Ortega-Martínez de Victoria L; García-Fernández de Villalta MJ
    Actas Dermosifiliogr; 2015; 106(1):61-2. PubMed ID: 24838226
    [No Abstract]   [Full Text] [Related]  

  • 7. Fox Fordyce disease: a side effect of laser therapy.
    Zargari O; Azimi SZ
    J Cosmet Laser Ther; 2020 Apr; 22(3):126-127. PubMed ID: 32506979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perifollicular xanthomatosis as the hallmark of axillary Fox-Fordyce disease: an evaluation of histopathologic features of 7 cases.
    Bormate AB; Leboit PE; McCalmont TH
    Arch Dermatol; 2008 Aug; 144(8):1020-4. PubMed ID: 18711075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological study of Fox-Fordyce disease.
    Kao PH; Hsu CK; Lee JY
    J Dermatol; 2009 Sep; 36(9):485-90. PubMed ID: 19712275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dilation of apocrine glands. A forgotten but helpful histopathological clue to the diagnosis of axillary Fox-Fordyce disease.
    Macarenco RS; Garces S JC
    Am J Dermatopathol; 2009 Jun; 31(4):393-7. PubMed ID: 19461248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fox-Fordyce disease: Insights from cases induced by laser hair removal.
    Byth LA; Byth J
    Australas J Dermatol; 2020 May; 61(2):188-189. PubMed ID: 31734939
    [No Abstract]   [Full Text] [Related]  

  • 12. [Perifollicular xanthomatosis as a key histological finding in Fox-Fordyce disease].
    Mataix J; Silvestre JF; Niveiro M; Lucas A; Pérez-Crespo M
    Actas Dermosifiliogr; 2008 Mar; 99(2):145-8. PubMed ID: 18346437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fox-Fordyce disease.
    Yost J; Robinson M; Meehan SA
    Dermatol Online J; 2012 Dec; 18(12):28. PubMed ID: 23286818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology, clinical findings, and management of Fox-Fordyce disease: A systematic review.
    Salloum A; Bouferraa Y; Bazzi N; Bou Zerdan M; Abi Chebl J; Chu T; Bachour J; Benedetto A
    J Cosmet Dermatol; 2022 Feb; 21(2):482-500. PubMed ID: 33817950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Axillary and perimamillary Fox-Fordyce disease (apocrine miliaria) in a 19-year-old woman].
    Hanner S; Schneiderbauer R; Enk A; Toberer F
    Hautarzt; 2018 Apr; 69(4):313-315. PubMed ID: 29110043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fox-Fordyce disease exacerbated by hyperhidrosis.
    Alikhan A; Gorouhi F; Zargari O
    Pediatr Dermatol; 2010; 27(2):162-5. PubMed ID: 20537067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary perifollicular xanthomatosis resembling Fox-Fordyce disease.
    Kossard S; Dwyer P
    Australas J Dermatol; 2004 May; 45(2):146-8. PubMed ID: 15068468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid remission with calcipotriol betamethasone in refractory Fox-Fordyce disease.
    Yang L; Zhang S; Wang T; He Z; Liu Y; Zdravković TP
    Dermatol Ther; 2020 Mar; 33(2):e13223. PubMed ID: 31917488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathology attributes of Fox-Fordyce disease.
    Brau Javier CN; Morales A; Sanchez JL
    Int J Dermatol; 2012 Nov; 51(11):1313-8. PubMed ID: 23067079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease.
    Kamada A; Saga K; Jimbow K
    J Am Acad Dermatol; 2003 Mar; 48(3):453-5. PubMed ID: 12637930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.